4.6 Review Book Chapter

LPA Receptors: Subtypes and Biological Actions

期刊

出版社

ANNUAL REVIEWS
DOI: 10.1146/annurev.pharmtox.010909.105753

关键词

lysophosphatidic acid; G protein-coupled receptor; autotaxin; brain; cancer; development

资金

  1. NIH [MH051699, NS048478, HD050685]
  2. Agency of Science, Technology, and Research National Science Scholarship, Singapore
  3. National Science Foundation
  4. NIH/NICHD
  5. NIDA Diversity Supplement Grant
  6. Scripps Translational Science Institute Pilot Study Award
  7. Novartis
  8. Korea Research Foundation [KRF-2006-352-E00018, KRF-2004-214-C00246]
  9. Capita Foundation Research Grant
  10. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050685] Funding Source: NIH RePORTER
  11. NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER
  12. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051699, R29MH051699] Funding Source: NIH RePORTER
  13. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048478] Funding Source: NIH RePORTER
  14. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019674] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Lysophosphatidic acid (LPA) is a small, ubiquitous phospholipid that acts as an extracellular signaling molecule by binding to and activating at least five known G protein-coupled receptors (GPCRs): LPA(1)-LPA(5). They are encoded by distinct genes named LPAR1-LPAR5 in humans and Lpar1-Lpar5 in mice. The biological roles of LPA are diverse and include developmental, physiological, and pathophysiological effects. I This diversity is mediated by broad and overlapping expression patterns and multiple downstream signaling pathways activated by cognate LPA receptors. Studies using cloned receptors and genetic knockout mice have been instrumental in uncovering the significance of this signaling system, notably involving basic cellular processes as well as multiple organ Systems Such,IS the nervous system. This has further provided valuable proof-of-concept data to support LPA receptors and LPA metabolic enzymes as targets for the treatment of medically important diseases that include neuropsychiatric disorders, neuropathic pain, infertility, cardiovascular disease, inflammation, fibrosis, and cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据